Acorda Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Acorda Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$19.6M, a 71% decline year-over-year.
  • Acorda Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$273M, a 807% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$265M, a 650% decline from 2022.
  • Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$35.3M, a 55.3% increase from 2021.
  • Acorda Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$79M, a 1.23% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$273M -$19.6M -$8.15M -71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$265M -$247M -$248M -92731% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$17.4M -$2.52M +$2.47M +49.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$19.8M -$3.63M +$10.3M +73.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$30.1M -$11.5M +$5.23M +31.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$35.3M $267K +$11.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$47.2M -$4.99M +$18M +78.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$65.2M -$13.9M +$1.77M +11.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$67M -$16.7M +$12.1M +42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$79M -$11.6M +$66.8M +85.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$146M -$23M -$39M -243% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$107M -$15.7M -$6.14M -64.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$101M -$28.8M -$22.6M -367% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$78.1M -$78.4M -$92.9M -641% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $14.8M $16M +$275M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$261M -$9.55M +$13.8M +59.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$274M -$6.17M +$37.2M +85.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$312M $14.5M +$63.8M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$375M -$259M -$288M -1017% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$87.8M -$23.4M -$82.4M -140% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$5.35M -$43.4M -$43.8M -9655% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $38.5M -$49.3M +$169M +77.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$130M $28.3M +$30.5M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$161M $59M +$56.3M +2090% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$217M $454K +$15.7M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$233M -$218M -$219M -30643% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$14M -$2.16M +$3.31M +60.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$17.3M $2.7M +$16.7M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$34.1M -$15.3M +$1.92M +11.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$36M $714K -$3.16M -81.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$32.8M -$5.47M -$31.2M -121% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$1.67M -$14M -$19.7M -347% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $18.1M -$17.2M -$15.9M -1265% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $34M $3.87M +$2.7M +232% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 $31.3M $25.7M +$4.86M +23.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $26.4M $5.69M -$5.29M -48.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $31.7M -$1.26M -$4.68M -137% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $36.4M $1.17M -$11.6M -90.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $48M $20.8M +$9.46M +83.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $38.5M $11M +$2.24M +25.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $36.3M $3.42M +$5.91M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $30.4M $12.7M +$11.4M +863% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $18.9M $11.4M +$1.01M +9.72% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $17.9M $8.74M +$3.68M +72.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $14.3M -$2.5M -$11.4M -128% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $25.6M $1.32M -$11.7M -89.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $37.3M $10.4M -$10.3M -49.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $47.6M $5.06M +$4.14M +450% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $43.5M $8.86M +$8.41M +1908% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $35.1M $13M +$8.91M +216% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $26.1M $20.7M +$7.4M +55.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $18.7M $920K +$6.63M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $12.1M $441K +$20.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 -$8.43M $4.12M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $13.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$5.71M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 -$20.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.